Altre lingue BioVaxys Technology Corp. Deutsche Boerse AG

Azioni

5LB

CA09076M1014

Mercato chiuso - Deutsche Boerse AG Altri mercati azionari 08:01:53 17/05/2024			Variaz. 5gg	Var. 1 gen.
0,0365 ^EUR	-.--%		-.--%	+107,39%

02/05	Biovaxys Technology Corp. Ritarda a depositare il bilancio intermedio per i tre mesi conclusi il 31 gennaio 2024	CI
10/04	Biovaxys e SpayVac-For-Wildlife, Inc. annunciano il lancio di una sperimentazione sul campo per l'immunocontraccezione su larga scala nell'industria dell'allevamento acquatico commerciale	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BioVaxys Technology Corp. Announces Failure to File Cease Trade Order	16/05
CSE Bulletin: Suspension - BioVaxys Technology Corp. (BIOV)	16/05
Canadian Investment Regulatory Organization Trading Halt - BIOV	16/05
BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement	10/05
BioVaxys Technology Corp. Closes First Tranche of Private Placement	04/05
Biovaxys Technology Corp. Delays to File Its Interim Financial Statements for the Three Months Ended January 31, 2024	02/05
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	02/05
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050	01/05
BioVaxys Technology Corp. Appoints Christopher Cherry as Chief Financial Officer	30/04
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	18/04
Biovaxys and SpayVac-For-Wildlife, Inc. Announce Launch of Field Trial for Large-Scale Immunocontraception in the Commercial Aquatic Farming Industry	10/04
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY	10/04
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	05/04
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMage	03/04
BioVaxys Technology Plans Private Placement; Down 5.9%	25/03
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT	22/03
BioVaxys Technology Corp. announced that it expects to receive CAD 1 million in funding	22/03
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	21/03
Down 17%, BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	07/03
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	07/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BioVaxys Technology Corp. Deutsche Boerse AG

Azioni

5LB

CA09076M1014

Altre lingue

Filtri